For example, CDDO-imidazolide induces G2/M cell cycle arrest in BRCA1-mutated breast cancer cells [18], while CDDO-Me significantly arrests cells in the G2/M and S phases in K562 cells [19]. Here, BRCA1 is linked to breast cancer.